-
Notifications
You must be signed in to change notification settings - Fork 0
/
Copy pathDucCCE.sql
139 lines (120 loc) · 193 KB
/
DucCCE.sql
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
-- MySQL dump 10.19 Distrib 10.3.39-MariaDB, for Linux (x86_64)
--
-- Host: localhost Database: ducprofiler
-- ------------------------------------------------------
-- Server version 10.3.39-MariaDB
/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8mb4 */;
/*!40103 SET @OLD_TIME_ZONE=@@TIME_ZONE */;
/*!40103 SET TIME_ZONE='+00:00' */;
/*!40014 SET @OLD_UNIQUE_CHECKS=@@UNIQUE_CHECKS, UNIQUE_CHECKS=0 */;
/*!40014 SET @OLD_FOREIGN_KEY_CHECKS=@@FOREIGN_KEY_CHECKS, FOREIGN_KEY_CHECKS=0 */;
/*!40101 SET @OLD_SQL_MODE=@@SQL_MODE, SQL_MODE='NO_AUTO_VALUE_ON_ZERO' */;
/*!40111 SET @OLD_SQL_NOTES=@@SQL_NOTES, SQL_NOTES=0 */;
--
-- Table structure for table `link`
--
DROP TABLE IF EXISTS `link`;
/*!40101 SET @saved_cs_client = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `link` (
`l_id` bigint(20) NOT NULL AUTO_INCREMENT,
`u_id` bigint(20) NOT NULL,
`l_token` varchar(100) NOT NULL,
`created_at` datetime NOT NULL DEFAULT current_timestamp(),
PRIMARY KEY (`l_id`),
KEY `conditions_ibfk_1` (`u_id`),
CONSTRAINT `conditions_ibfk_1` FOREIGN KEY (`u_id`) REFERENCES `userinfo` (`u_id`)
) ENGINE=InnoDB AUTO_INCREMENT=117 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;
--
-- Dumping data for table `link`
--
LOCK TABLES `link` WRITE;
/*!40000 ALTER TABLE `link` DISABLE KEYS */;
INSERT INTO `link` VALUES (28,35,'7h7gx1k','2021-08-27 14:41:23'),(32,39,'ZavrSK2','2021-09-07 15:31:01'),(34,41,'N4O2EoU','2021-09-07 16:01:01'),(35,42,'hCLkXaT','2021-09-20 11:34:27'),(39,45,'8mDIRCg','2021-09-29 10:47:29'),(40,46,'csdrHyH','2021-09-29 15:32:36'),(42,48,'le2Qtjk','2021-10-12 09:50:19'),(56,52,'nfm2nTY','2022-01-28 14:22:12'),(57,54,'o3Gt2CD','2022-01-28 15:32:48'),(60,40,'lbQMpO6','2022-02-11 15:14:52'),(61,37,'JwiLDhU','2022-02-11 15:31:02'),(63,56,'h3N1GOF','2022-02-11 16:11:33'),(65,58,'lkc9GY1','2022-02-20 17:29:40'),(73,47,'lTx2acs','2022-04-22 12:58:23'),(76,59,'1U7bSkk','2022-05-20 15:04:12'),(80,53,'fiCAiK3','2022-06-27 12:35:15'),(83,38,'UhSDZZ0','2022-08-01 13:38:40'),(84,57,'WUfZJnU','2022-09-05 14:30:20'),(88,61,'k9AL7CM','2022-10-12 13:41:30'),(91,62,'iHxeikr','2022-11-24 14:46:39'),(93,64,'SyTtOoy','2022-12-12 08:37:56'),(94,36,'SYluE8L','2023-01-01 21:05:27'),(95,65,'4DtoSIP','2023-01-01 21:05:34'),(98,66,'ghn3z3s','2023-01-25 16:40:49'),(99,67,'PNXAe2z','2023-01-25 16:43:01'),(100,68,'KH5txoL','2023-01-26 11:34:25'),(101,50,'ucoavir','2023-01-26 13:23:21'),(104,70,'2fezZ0X','2023-01-30 16:42:51'),(105,71,'PV5yiUF','2023-02-02 11:16:49'),(106,60,'bC37rBo','2023-02-10 11:01:12'),(108,51,'FuYnmNl','2023-02-21 15:07:33'),(109,72,'dGNzD3H','2023-02-24 15:08:23'),(110,73,'VFGzC6t','2023-02-28 11:37:53'),(111,63,'k1YCaXv','2023-03-09 11:45:02'),(112,69,'eBE0Wkq','2023-03-12 15:20:10'),(113,49,'O2fBKVH','2023-03-28 09:08:44'),(114,34,'JtF9tqG','2023-05-25 14:37:05'),(115,43,'kd2xvC1','2023-06-06 09:05:14'),(116,74,'GPRdC8X','2023-08-22 09:02:41');
/*!40000 ALTER TABLE `link` ENABLE KEYS */;
UNLOCK TABLES;
--
-- Table structure for table `profile`
--
DROP TABLE IF EXISTS `profile`;
/*!40101 SET @saved_cs_client = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `profile` (
`p_id` bigint(20) NOT NULL AUTO_INCREMENT,
`u_id` bigint(20) DEFAULT NULL,
`pr_id` varchar(1000) DEFAULT NULL,
`p_name` varchar(500) DEFAULT NULL,
`p_data` longtext CHARACTER SET utf8mb4 COLLATE utf8mb4_bin DEFAULT NULL,
PRIMARY KEY (`p_id`),
KEY `profile` (`u_id`),
CONSTRAINT `profile_ibfk_1` FOREIGN KEY (`u_id`) REFERENCES `userinfo` (`u_id`)
) ENGINE=InnoDB AUTO_INCREMENT=262 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;
--
-- Dumping data for table `profile`
--
LOCK TABLES `profile` WRITE;
/*!40000 ALTER TABLE `profile` DISABLE KEYS */;
INSERT INTO `profile` VALUES (162,55,'pr_3d9iyx0ur','ERKReg','{\r\n \"profile\": {\r\n \"profileName\": \"ERKReg\",\r\n \"profileVersion\": \"v0.1\",\r\n \"profileId\": \"pr_3d9iyx0ur\",\r\n \"creationDate\": \"31/01/2022\",\r\n \"ducVersion\": \"Jan 2022\",\r\n \"permissionMode\": \"Not Stated\",\r\n \"resources\": {\r\n \"resourceName\": \"ERKReg\"\r\n },\r\n \"conditions\": [\r\n {\r\n \"conditionTermLabel\": \"Use by a commercial entity\",\r\n \"ruleApplication\": \"Applicable\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Jurisdiction\",\r\n \"rule\": \"OBLIGATED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Time period of use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Research use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Clinical use\",\r\n \"rule\": \"OBLIGATED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Disease specific use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Use as control\",\r\n \"rule\": \"NO STATED RULE\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Profit motivated use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Collaboration\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Fees\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Return of non-incidental findings\",\r\n \"ruleApplication\": \"Not Applicable\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Return of incidental findings\",\r\n \"ruleApplication\": \"Not Applicable\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Re-identification of individuals\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": {\r\n \"resourceName\": \"ERKReg\"\r\n },\r\n \"Conditions\": [\r\n {\r\n \"conditionTermLabel\": \"Use by a commercial entity\",\r\n \"ruleApplication\": \"Applicable\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Jurisdiction\",\r\n \"rule\": \"OBLIGATED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Time period of use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Research use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Clinical use\",\r\n \"rule\": \"OBLIGATED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Disease specific use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Use as control\",\r\n \"rule\": \"NO STATED RULE\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Profit motivated use\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Collaboration\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Fees\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Whole of Asset\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Return of non-incidental findings\",\r\n \"ruleApplication\": \"Not Applicable\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Return of incidental findings\",\r\n \"ruleApplication\": \"Not Applicable\"\r\n },\r\n {\r\n \"conditionTermLabel\": \"Re-identification of individuals\",\r\n \"rule\": \"PERMITTED\",\r\n \"scope\": \"Part of Asset\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(181,43,'bf06fbc8-985b-46e0-b9fe-d6bbd0a8ea9f','VASCA registry RadboudUMC CCE Profile','{\r\n \"profile\": {\r\n \"profileName\": \"VASCA registry RadboudUMC CCE Profile\",\r\n \"profileVersion\": \"V0.1\",\r\n \"profileId\": \"bf06fbc8-985b-46e0-b9fe-d6bbd0a8ea9f\",\r\n \"creationDate\": \"2022-03-10\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDataLevel\": \"DATASET\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"conditionDetailLabel\": \"GDPR\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"conditionDetailLabel\": \"depending on consent of participant\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"conditionDetailLabel\": \"by recipient\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDataLevel\": \"DATASET\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"conditionDetailLabel\": \"GDPR\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"conditionDetailLabel\": \"depending on consent of participant\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"conditionDetailLabel\": \"by recipient\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(183,59,'1824ba8c-2285-4791-8dfd-048ec5522190','FAIRDDP','{\r\n \"profile\": {\r\n \"profileName\": \"FAIRDDP\",\r\n \"profileVersion\": \"0.0.1\",\r\n \"profileId\": \"1824ba8c-2285-4791-8dfd-048ec5522190\",\r\n \"creationDate\": \"2022-03-24\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Duchenne Data Platform\",\r\n \"resourceDescription\": \"Patient-led registry\",\r\n \"resourceDataLevel\": \"METADATA\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"Duchenne Parent Project\",\r\n \"resourceOrganisationRole\": \"Patient Organisation\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Duchenne Data Platform\",\r\n \"resourceDescription\": \"Patient-led registry\",\r\n \"resourceDataLevel\": \"METADATA\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"Duchenne Parent Project\",\r\n \"resourceOrganisationRole\": \"Patient Organisation\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(184,43,'6b17d1a7-53b7-41a9-ba02-4690a364aad8','VASCA registry Record Level','{\r\n \"profile\": {\r\n \"profileName\": \"VASCA registry Record Level\",\r\n \"profileVersion\": \"V0.1\",\r\n \"profileId\": \"6b17d1a7-53b7-41a9-ba02-4690a364aad8\",\r\n \"creationDate\": \"2022-05-20\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDescription\": \"data for Vascular Anomalies\",\r\n \"resourceDataLevel\": \"RECORD\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"VASCERN\",\r\n \"resourceOrganisationRole\": \"ERN\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"conditionDetailLabel\": \"the whole world\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"otherConsiderations\": \"Only if GDPR is respected\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Is this for the secondary user? Or responsibilty for primary user?\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDescription\": \"data for Vascular Anomalies\",\r\n \"resourceDataLevel\": \"RECORD\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"VASCERN\",\r\n \"resourceOrganisationRole\": \"ERN\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"conditionDetailLabel\": \"the whole world\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"otherConsiderations\": \"Only if GDPR is respected\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Is this for the secondary user? Or responsibilty for primary user?\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(185,60,'bef5b6fb-9435-4e02-be94-92fca968176d','ERN eUROGEN test','{\"profile\":{\"profileName\":\"ERN eUROGEN test\",\"profileVersion\":\"test\",\"profileID\":\"\"},\"resources\":[null],\"Conditions\":[{\"useConditionLabel\":\"Regulatory jurisdiction\",\"conditionDetailLabel\":\"Only in regions subject to GDPR or with an adequacy agreement\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"Only after approval of the Data Access Committee and the HCPs that provided the data.\"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"conditionDetailLabel\":\"In regions not subject to GDPR, but with an adequacy agreement\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"Use of the data in regions not subject to the GDPR is permitted for patients who permitted this use in the ICF, after approval of the Data Access Committee and the HCPs that provided the data.\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"Commercial entities can use data of patients who permitted this use in the ICF, after approval of the Data Access Committee and the HCPs that provided the data.\"}]}'),(186,50,'c2427b86-943a-411f-9295-4b67a6290070','IRCCS Istituto G. Gaslini - Genetic Biobank','{\"profile\":{\"profileName\":\"IRCCS Istituto G. Gaslini - Genetic Biobank\",\"profileVersion\":\"version 3\",\"profileID\":\"\"},\"resources\":[null],\"Conditions\":[{\"useConditionLabel\":\"Clinical care\",\"conditionDetailLabel\":\"use for diagnosis purpose\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"only if a specific authorisation in the informed consent is present\"},{\"useConditionLabel\":\"Clinical research\",\"conditionDetailLabel\":\"use for research purposes , including research to improve diagnosis and treatment, in the field of the disease for which the biological materials have been biobanked\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"only if a specific authorisation in the informed consent is present\"},{\"useConditionLabel\":\"Collaboration\",\"conditionDetailLabel\":\"\",\"rule\":\"No Requirements\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"The collaboration is evaluated when appropriate\"},{\"useConditionLabel\":\"Disease specific use\",\"conditionDetailLabel\":\"relating to the field of the disease for which the biological materials have been biobanked\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"disease focus: rare metabolic disorders, chromosome disorders, neurological diseases and overgrowth disorders\"},{\"useConditionLabel\":\"Ethics Approval\",\"conditionDetailLabel\":\"Protocol number, date and name of Ethical Commettee/Review Board\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"For research use only\"},{\"useConditionLabel\":\"Fees\",\"conditionDetailLabel\":\"distribution service related to funded projects is subject to cost recovery\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"NA for collaboration projects\"},{\"useConditionLabel\":\"Geographical area\",\"conditionDetailLabel\":\" use in EU and non EU countries\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\" the use, in countries not covered by GDPR, requires specific authorisation included in the informed consent\"},{\"useConditionLabel\":\"Profit motivated use\",\"conditionDetailLabel\":\"undefined\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Publication\",\"conditionDetailLabel\":\"The recipient agrees to make available to the resource the paper reprint (or pdf format) in case of publication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"The recipients is aked to acknowledge the biobank in their publication\"},{\"useConditionLabel\":\"Publication moratorium\",\"conditionDetailLabel\":\"\",\"rule\":\"No Requirements\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Re-Identification of individuals\",\"conditionDetailLabel\":\"when biological materials stored are used for diagnosis purposes \",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"conditionDetailLabel\":\" use in EU and non-EU countries\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"use in countries that are not covered by GDPR requires specific authorisation in the informed consent\"},{\"useConditionLabel\":\"Research use\",\"conditionDetailLabel\":\"use for research purposes in the field of the disease for which the biological materials have been biobanked\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"disease focus: rare metabolic disorders, chromosome disorders, neurological diseases and overgrowth disorders\"},{\"useConditionLabel\":\"Return of incidental findings\",\"conditionDetailLabel\":\"only for results that are relevant to the health of the participant\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Return of results\",\"conditionDetailLabel\":\"The recipient shall make available in confidence to the resource a final report of the results of the project\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Time period of use\",\"conditionDetailLabel\":\"The recipient is permitted to use the biological material until completion of the project for which the material has been required to the biobank. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"Terms and conditions for the use, storage and disposal of the biological material are stated in the MTA\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"conditionDetailLabel\":\"only if it has been authorised in the informed consent \",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"User authentication\",\"conditionDetailLabel\":\"To request biological materials the recipient should register themself to the resource website and to fill in a specific form\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"}]}'),(189,38,'b3e25ad1-f219-4869-87f8-f8ad032fc380','test','{\r\n \"profile\": {\r\n \"profileName\": \"test\",\r\n \"profileId\": \"b3e25ad1-f219-4869-87f8-f8ad032fc380\",\r\n \"creationDate\": \"2022-08-01\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"test\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"uk\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"test\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"uk\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(190,38,'501207cd-2ea2-4251-a3a8-ca8b73f87911','test','{\r\n \"profile\": {\r\n \"profileName\": \"test\",\r\n \"profileId\": \"501207cd-2ea2-4251-a3a8-ca8b73f87911\",\r\n \"creationDate\": \"2022-08-01\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"test\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"uk\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"test\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"uk\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(191,57,'de018258-7144-4381-8ca0-b2847284db0b','test profile of a biobank collection','{\r\n \"profile\": {\r\n \"profileName\": \"test profile of a biobank collection\",\r\n \"profileVersion\": \"0.2\",\r\n \"profileId\": \"de018258-7144-4381-8ca0-b2847284db0b\",\r\n \"creationDate\": \"2022-09-05\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"collection of lost tears\",\r\n \"resourceDescription\": \"we collect tears and analyse the memory hidden in them\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"Biobank of the Lost Tears\",\r\n \"resourceOrganisationRole\": \"DUC Manager\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"otherConsiderations\": \"there are some samples (below of 10 percent) having restrictions to be used commercially\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"europe\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Wordwide\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"DTA obligatory\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"no restrictions\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"subchohort black tears\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"PI of cohort has to be last author\"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"collection of lost tears\",\r\n \"resourceDescription\": \"we collect tears and analyse the memory hidden in them\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"Biobank of the Lost Tears\",\r\n \"resourceOrganisationRole\": \"DUC Manager\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"otherConsiderations\": \"there are some samples (below of 10 percent) having restrictions to be used commercially\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"europe\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Wordwide\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"DTA obligatory\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"no restrictions\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"subchohort black tears\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"PI of cohort has to be last author\"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(192,51,'f44f7ae1-48e2-4858-9ae1-2218a631dc82','LeMHR','{\"profile\":{\"profileName\":\"LeMHR Test 1\",\"profileVersion\":\"0.2\",\"profileID\":\"\"},\"resource\":[{\"resourceName\":\"LeMHR Test 1\",\"resourceDescription\":\"Metatdata relating to the Leicester medical data sources\",\"resourceDataLevel\":[\"Dataset\"],\"resourceContacts\":[\"sg307@leicester.ac.uk \"],\"resourceOrganisations\":[{\"resourceOrganisationName\":\"University of Leicester\",\"resourceOrganisationRole\":\"University of Leicester\"}]}],\"Conditions\":[{\"useConditionLabel\":\"Clinical research\",\"conditionDetailLabel\":\"Please contact the resource provider directly to discuss access \",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"conditionDetailLabel\":\"For Use by UOL and collaborators only \",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"}]}'),(193,51,'3f93f31b-cbb5-419f-a98c-dab0e24fc9ce','DASH','{\"profile\":{\"profileName\":\"DASH Data Test\",\"profileVersion\":\"0.1\",\"profileID\":\"\"},\"resource\":[{\"resourceName\":\"DASH data\",\"resourceDescription\":\"Meltcurve data from DASH testing of SNP discrimination \",\"resourceDataLevel\":\"Dataset\"}],\"Conditions\":[{\"useConditionLabel\":\"Clinical care\",\"conditionDetailLabel\":\"Not validated Methodology \",\"rule\":\"Forbidden\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Research use\",\"conditionDetailLabel\":\"undefined\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"\"}]}'),(195,61,'2e3f576a-ca57-4c2e-bc52-6e0657717d46','Echo1','{\"profile\":{\"profileName\":\"Echo1\",\"profileId\":\"2e3f576a-ca57-4c2e-bc52-6e0657717d46\",\"creationDate\":\"2022-09-11\",\"ducVersion\":\"0.0.1\",\"permissionMode\":null,\"resources\":[{\"resourceName\":\"GDPRCompliantBiobank\",\"resourceDataLevel\":\"Biobank\"}],\"conditions\":[{\"useConditionLabel\":\"Clinical care\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"Our data and samples are strictly research-grade. They don\'t meet the criteria for clinical use\"},{\"useConditionLabel\":\"Clinical research\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Subject to submission of a detailed clinical study protocol by the requestor\"},{\"useConditionLabel\":\"Disease specific use\",\"rule\":\"Obligated\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Approximately 10% of our research participants have opted out of research projects outside of Neurodegenerative Diseases\"},{\"useConditionLabel\":\"Ethics Approval\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"We generally require a preexisting ethics approval. However, under certain circumstances, our institution will consider access requests without an ethics approval. In these cases, our own IRB will perform an ethics assessment (for an additional fee)\",\"otherConsiderations\":\"We may make exceptions where sample & data requestors are from countries and/or institutions that do not require an ethics approval for retrospective research projects. The requestors must demonstrate this (e.g. refer to the relevant national law)\"},{\"useConditionLabel\":\"Fees\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"In the case of sample transfers, the requesting researchers shall be responsible for the associated costs. An ethics review by our IRB is also subject to fees (see below)\"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Forbidden\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Approximately 10% of our samples and associated data cannot be transferred outside the EU\"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"The remaining 90% can be transferred outside the EU, subject to appropriate safeguards (in particular, signing of Standard Contractual Clauses)\"},{\"useConditionLabel\":\"Profit motivated use\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Same as use by commercial entity: subject to approval by our DSAC\"},{\"useConditionLabel\":\"Publication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Standard Acknowledgement statement must be included in manuscripts. \"},{\"useConditionLabel\":\"Re-Identification of individuals\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Research use\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Return of incidental findings\",\"rule\":\"Obligated\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"95% of our research participants opted in to receive health-related incidental findings. Access to our collections is contingent upon the requesting researchers\' written commitment to routinely reporting health-related incidental findings.\"},{\"useConditionLabel\":\"Return of results\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Enriched and derived data must be deposited back into the data repository\"},{\"useConditionLabel\":\"Time period of use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"1 year maximum, as also stated in our Data and Sample Use Conditions agreement to be signed prior to granting access. Renewable, but requires an additional approval by our DSAC\"},{\"useConditionLabel\":\"Use as control\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Subject to approval by our DSAC\",\"otherConsiderations\":\"Only applies to commercial projects. (i.e. not relevant to uses by commercial entities as part of a non-commercial research project)\"}],\"comments\":[{\"Comments Regarding DUC_Profiler\":\"\",\"Comments Regarding CCE\":\"Missing item 1: GDPR legal basis. \\nWe do not allow access and use of our data by parties that rely on Art. 6(1)(a) GDPR - Consent; Requesting party must be relying on another GDPR legal basis to process the data (e.g. public interest or legitimate interest). \\nMissing Item 2: genetic analysis cannot be performed on some of the samples (Scope: part of the resource)\"}]},\"resource\":[{\"resourceName\":\"GDPRCompliantBiobank\",\"resourceDataLevel\":\"Biobank\"}],\"Conditions\":[{\"useConditionLabel\":\"Clinical care\",\"conditionDetailLabel\":\"undefined\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"Our data and samples are strictly research-grade. They don\'t meet the criteria for clinical use\"},{\"useConditionLabel\":\"Clinical research\",\"conditionDetailLabel\":\"Subject to submission of a detailed clinical study protocol by the requestor\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Disease specific use\",\"conditionDetailLabel\":\"\",\"rule\":\"Obligated\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"Approximately 10% of our research participants have opted out of research projects outside of Neurodegenerative Diseases\"},{\"useConditionLabel\":\"Ethics Approval\",\"conditionDetailLabel\":\"We generally require a preexisting ethics approval. However, under certain circumstances, our institution will consider access requests without an ethics approval. In these cases, our own IRB will perform an ethics assessment (for an additional fee)\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"We may make exceptions where sample & data requestors are from countries and/or institutions that do not require an ethics approval for retrospective research projects. The requestors must demonstrate this (e.g. refer to the relevant national law)\"},{\"useConditionLabel\":\"Fees\",\"conditionDetailLabel\":\"In the case of sample transfers, the requesting researchers shall be responsible for the associated costs. An ethics review by our IRB is also subject to fees (see below)\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Geographical area\",\"conditionDetailLabel\":\"\",\"rule\":\"Forbidden\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"Approximately 10% of our samples and associated data cannot be transferred outside the EU\"},{\"useConditionLabel\":\"Geographical area\",\"conditionDetailLabel\":\"\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"The remaining 90% can be transferred outside the EU, subject to appropriate safeguards (in particular, signing of Standard Contractual Clauses)\"},{\"useConditionLabel\":\"Profit motivated use\",\"conditionDetailLabel\":\"\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"Same as use by commercial entity: subject to approval by our DSAC\"},{\"useConditionLabel\":\"Publication\",\"conditionDetailLabel\":\"Standard Acknowledgement statement must be included in manuscripts. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Re-Identification of individuals\",\"conditionDetailLabel\":\"undefined\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Research use\",\"conditionDetailLabel\":\"undefined\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Return of incidental findings\",\"conditionDetailLabel\":\"\",\"rule\":\"Obligated\",\"scope\":\"Part of Resource\",\"otherConsiderations\":\"95% of our research participants opted in to receive health-related incidental findings. Access to our collections is contingent upon the requesting researchers\' written commitment to routinely reporting health-related incidental findings.\"},{\"useConditionLabel\":\"Return of results\",\"conditionDetailLabel\":\"\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"Enriched and derived data must be deposited back into the data repository\"},{\"useConditionLabel\":\"Time period of use\",\"conditionDetailLabel\":\"1 year maximum, as also stated in our Data and Sample Use Conditions agreement to be signed prior to granting access. Renewable, but requires an additional approval by our DSAC\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Use as control\",\"conditionDetailLabel\":\"undefined\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"conditionDetailLabel\":\"Subject to approval by our DSAC\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"Only applies to commercial projects. (i.e. not relevant to uses by commercial entities as part of a non-commercial research project)\"}]}'),(196,62,'4f5d3797-4e6e-458c-9b72-c20784b74841','ERN-Registry-Research-ICF_CCEs applicable to all versions','{\r\n \"profile\": {\r\n \"profileName\": \"ERN-Registry-Research-ICF_CCEs applicable to all versions\",\r\n \"profileId\": \"4f5d3797-4e6e-458c-9b72-c20784b74841\",\r\n \"creationDate\": \"2022-11-24\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDescription\": \"https://github.com/ejp-rd-vp/resource-metadata-schema/blob/master/docs/patient-registry.md\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"info@erica-rd.eu \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"European Reference Network\",\r\n \"resourceOrganisationRole\": \"Data Controller\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. \\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\".\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\",\r\n \"otherConsiderations\": \"GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"Limited number of characters in the fields \\\"condition detail\\\" and \\\"other consideration\\\". Some other consideration being put in the field \\\"Comments regarding CCE\\\".\\nThe information provided in the \\\"Comments regarding CCE\\\" needs to be displayed in the \\\"Summary\\\". It is not for the moment\\n\",\r\n \"Comments Regarding CCE\": \"-Use condition \\\"fee\\\": depends on ERN data strategy and the type of stakeholder requesting data access (e.g., fees may apply for industry requesting access to registry data).\\n-Use condition \\\"Return of results\\\": The results of the research will be communicated through the mean decided by the ERN (e.g., registry website [The information about projects given access to registry data is publicly available on the registry website.], OR information provided by the patient’s medical doctor upon request, OR publication in scientific journals where personal data are not provided, etc.). The privacy of the patient\'s data will always be protected as described in the ICF.\\n-Use condition \\\"publication\\\": is considered as being part of the use condition \\\"return of results\\\"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDescription\": \"https://github.com/ejp-rd-vp/resource-metadata-schema/blob/master/docs/patient-registry.md\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"info@erica-rd.eu \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"European Reference Network\",\r\n \"resourceOrganisationRole\": \"Data Controller\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. \\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\".\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\",\r\n \"otherConsiderations\": \"GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"Limited number of characters in the fields \\\"condition detail\\\" and \\\"other consideration\\\". Some other consideration being put in the field \\\"Comments regarding CCE\\\".\\nThe information provided in the \\\"Comments regarding CCE\\\" needs to be displayed in the \\\"Summary\\\". It is not for the moment\\n\",\r\n \"Comments Regarding CCE\": \"-Use condition \\\"fee\\\": depends on ERN data strategy and the type of stakeholder requesting data access (e.g., fees may apply for industry requesting access to registry data).\\n-Use condition \\\"Return of results\\\": The results of the research will be communicated through the mean decided by the ERN (e.g., registry website [The information about projects given access to registry data is publicly available on the registry website.], OR information provided by the patient’s medical doctor upon request, OR publication in scientific journals where personal data are not provided, etc.). The privacy of the patient\'s data will always be protected as described in the ICF.\\n-Use condition \\\"publication\\\": is considered as being part of the use condition \\\"return of results\\\"\"\r\n }\r\n ]\r\n}'),(197,63,'dbe98bb9-9bb1-439e-acaf-c2aa9aa7e5a9','ERN-Registry-Research-ICF_CCEs applicable to all versions_No1','{\r\n \"profile\": {\r\n \"profileName\": \"ERN-Registry-Research-ICF_CCEs applicable to all versions_No1\",\r\n \"profileVersion\": \"v1.0\",\r\n \"profileId\": \"dbe98bb9-9bb1-439e-acaf-c2aa9aa7e5a9\",\r\n \"creationDate\": \"2022-11-28\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDescription\": \"https://github.com/ejp-rd-vp/resource-metadata-schema/blob/master/docs/patient-registry.md\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"info@erica-rd.eu \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"European Reference Network\",\r\n \"resourceOrganisationRole\": \"Data Controller\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. \\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\".\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Is it the same as profit motivated use?\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be transferred to non-EU countries, in compliance with GDPR, to support projects aimed to improve healthcare. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be linked to existing databases/registries to improve healthcare. \",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"It should be \\\"permitted\\\" instead of \\\"obligated\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition. \",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"It should be \\\"permitted\\\" instead of \\\"obligated\\\". I am not sure the re-contact should be included under \\\"collaboration\\\" \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE INFORMED by my medical doctor about any incidental finding that is directly relevant to my personal health or to the health of my family members. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDescription\": \"https://github.com/ejp-rd-vp/resource-metadata-schema/blob/master/docs/patient-registry.md\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"info@erica-rd.eu \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"European Reference Network\",\r\n \"resourceOrganisationRole\": \"Data Controller\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. \\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\".\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Is it the same as profit motivated use?\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be transferred to non-EU countries, in compliance with GDPR, to support projects aimed to improve healthcare. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be linked to existing databases/registries to improve healthcare. \",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"It should be \\\"permitted\\\" instead of \\\"obligated\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition. \",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"It should be \\\"permitted\\\" instead of \\\"obligated\\\". I am not sure the re-contact should be included under \\\"collaboration\\\" \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE INFORMED by my medical doctor about any incidental finding that is directly relevant to my personal health or to the health of my family members. \",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(198,63,'85993819-6d71-4f53-87af-11164d653d24','ERN-Registry-Research-ICF_CCEs applicable to all versions_No2','{\r\n \"profile\": {\r\n \"profileName\": \"ERN-Registry-Research-ICF_CCEs applicable to all versions_No2\",\r\n \"profileVersion\": \"v1.0\",\r\n \"profileId\": \"85993819-6d71-4f53-87af-11164d653d24\",\r\n \"creationDate\": \"2022-11-28\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDescription\": \"https://github.com/ejp-rd-vp/resource-metadata-schema/blob/master/docs/patient-registry.md\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"info@erica-rd.eu \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"European Reference Network\",\r\n \"resourceOrganisationRole\": \"Data Controller\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. \\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\".\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be transferred to non-EU countries, in compliance with GDPR, to support projects aimed to improve healthcare. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be linked to existing databases/registries to improve healthcare. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition. \\n\\nI WOULD LIKE TO BE INFORMED by my medical doctor about any incidental finding that is directly relevant to my personal healt\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDescription\": \"https://github.com/ejp-rd-vp/resource-metadata-schema/blob/master/docs/patient-registry.md\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"info@erica-rd.eu \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"European Reference Network\",\r\n \"resourceOrganisationRole\": \"Data Controller\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. \\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\\nThe use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\".\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Re-Identification of individuals\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided.\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"otherConsiderations\": \"GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be transferred to non-EU countries, in compliance with GDPR, to support projects aimed to improve healthcare. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be linked to existing databases/registries to improve healthcare. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition. \",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition. \\n\\nI WOULD LIKE TO BE INFORMED by my medical doctor about any incidental finding that is directly relevant to my personal healt\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(199,64,'ceb3f32d-9790-460f-812f-1a69e7ee9507','My first profile','{\r\n \"profile\": {\r\n \"profileName\": \"My first profile\",\r\n \"profileVersion\": \"0.0.1\",\r\n \"profileId\": \"ceb3f32d-9790-460f-812f-1a69e7ee9507\",\r\n \"creationDate\": \"2022-12-12\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Morris biobank\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Morris biobank\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(200,64,'f3bb77db-8cb7-4417-8c19-ca83304eb9b6','epnd example','{\r\n \"profile\": {\r\n \"profileName\": \"epnd example\",\r\n \"profileVersion\": \"0.0.1\",\r\n \"profileId\": \"f3bb77db-8cb7-4417-8c19-ca83304eb9b6\",\r\n \"creationDate\": \"2022-12-12\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"LifeLines\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"EU only\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"fee for service\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"LifeLines\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"EU only\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"fee for service\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding DUC_Profiler\": \"\",\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(202,36,'','',NULL),(203,36,'','',NULL),(204,36,'','',NULL),(205,36,'','','1zqjcr\'\"(){}<x>:/1zqjcr;9'),(206,36,'','',NULL),(207,36,'','',NULL),(208,36,'','',NULL),(209,36,'','',NULL),(210,36,'','',NULL),(211,36,'','',NULL),(212,36,'','',NULL),(213,36,'','',NULL),(214,36,'','',NULL),(215,36,'','',NULL),(216,36,'1zqjcr\'\"(){}<x>:/1zqjcr;9','',NULL),(217,36,NULL,'',NULL),(218,36,NULL,'1zqjcr\'\"(){}<x>:/1zqjcr;9',NULL),(220,36,NULL,NULL,NULL),(221,65,NULL,NULL,NULL),(224,34,'c1a09f5c-e467-4051-9582-f1141176ec11','Profile1','{\r\n \"profile\": {\r\n \"profileName\": \"Profile1\",\r\n \"profileVersion\": \"V.1\",\r\n \"profileId\": \"c1a09f5c-e467-4051-9582-f1141176ec11\",\r\n \"creationDate\": \"2023-01-25\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"bvnbvnvb\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"c1 ;c2 ;c3 \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"org1\",\r\n \"resourceOrganisationRole\": \"123\"\r\n },\r\n {\r\n \"resourceOrganisationName\": \"org2\",\r\n \"resourceOrganisationRole\": \"123\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"any details\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"details\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"bvnbvnvb\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"c1 ;c2 ;c3 \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"org1\",\r\n \"resourceOrganisationRole\": \"123\"\r\n },\r\n {\r\n \"resourceOrganisationName\": \"org2\",\r\n \"resourceOrganisationRole\": \"123\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"any details\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"details\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(225,34,'62df4a77-80a6-4336-b5ee-ea166a7b5e7d','Profile1','{\r\n \"profile\": {\r\n \"profileName\": \"Profile1\",\r\n \"profileVersion\": \"V.1\",\r\n \"profileId\": \"62df4a77-80a6-4336-b5ee-ea166a7b5e7d\",\r\n \"creationDate\": \"2023-01-25\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"bvnbvnvb\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"c1 ;c2 ;c3 \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"org1\",\r\n \"resourceOrganisationRole\": \"123\"\r\n },\r\n {\r\n \"resourceOrganisationName\": \"org2\",\r\n \"resourceOrganisationRole\": \"123\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"any details\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"details\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"bvnbvnvb\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"c1 ;c2 ;c3 \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"org1\",\r\n \"resourceOrganisationRole\": \"123\"\r\n },\r\n {\r\n \"resourceOrganisationName\": \"org2\",\r\n \"resourceOrganisationRole\": \"123\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"any details\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"details\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(226,34,'4c12ecc1-4f97-4ced-a0b7-414ef52554e1','Profile1','{\r\n \"profile\": {\r\n \"profileName\": \"Profile1\",\r\n \"profileVersion\": \"v.2\",\r\n \"profileId\": \"4c12ecc1-4f97-4ced-a0b7-414ef52554e1\",\r\n \"creationDate\": \"2023-01-25\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"gfhgfhfg\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"dd \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"hgjh\",\r\n \"resourceOrganisationRole\": \"ghgfh\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"dsd\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"gfhgfhfg\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"dd \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"hgjh\",\r\n \"resourceOrganisationRole\": \"ghgfh\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"dsd\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(227,34,'911c3bcb-2883-49f5-990e-9d9c01706ef9','Profile1','{\r\n \"profile\": {\r\n \"profileName\": \"Profile1\",\r\n \"profileVersion\": \"V.1\",\r\n \"profileId\": \"911c3bcb-2883-49f5-990e-9d9c01706ef9\",\r\n \"creationDate\": \"2023-01-25\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"gfhgfhfg\",\r\n \"resourceDataLevel\": \"Guideline\",\r\n \"resourceContacts\": \"dd \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"hgjh\",\r\n \"resourceOrganisationRole\": \"fdgfdg\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"dd\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"gfhgfhfg\",\r\n \"resourceDataLevel\": \"Guideline\",\r\n \"resourceContacts\": \"dd \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"hgjh\",\r\n \"resourceOrganisationRole\": \"fdgfdg\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"dd\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(228,66,'cf194d0b-d8d6-4f66-a472-f48ab06fc641','Profile1','{\r\n \"profile\": {\r\n \"profileName\": \"Profile1\",\r\n \"profileId\": \"cf194d0b-d8d6-4f66-a472-f48ab06fc641\",\r\n \"creationDate\": \"2023-01-25\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"gfhgfhfg\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"dc ;dds \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"hgjh\",\r\n \"resourceOrganisationRole\": \"fdgfdg\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"gfhgfhfg\",\r\n \"resourceDataLevel\": \"Patient Registry\",\r\n \"resourceContacts\": \"dc ;dds \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"hgjh\",\r\n \"resourceOrganisationRole\": \"fdgfdg\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(229,67,'015bcf2a-0426-44f6-946e-b5a5eccefb39','Profile1','{\r\n \"profile\": {\r\n \"profileName\": \"Profile1\",\r\n \"profileVersion\": \"V.1\",\r\n \"profileId\": \"015bcf2a-0426-44f6-946e-b5a5eccefb39\",\r\n \"creationDate\": \"2023-01-25\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"bvnbvnvb\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"c1 ;c2 ;c3 \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"org1\",\r\n \"resourceOrganisationRole\": \"123\"\r\n },\r\n {\r\n \"resourceOrganisationName\": \"org2\",\r\n \"resourceOrganisationRole\": \"123\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"any details\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"details\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Asset 1\",\r\n \"resourceDescription\": \"bvnbvnvb\",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceContacts\": \"c1 ;c2 ;c3 \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"org1\",\r\n \"resourceOrganisationRole\": \"123\"\r\n },\r\n {\r\n \"resourceOrganisationName\": \"org2\",\r\n \"resourceOrganisationRole\": \"123\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"any details\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"details\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(230,68,'315390ab-d10f-41ca-adc8-b49de1978105','tiziana.franchin','{\"profile\":{\"profileName\":\"tiziana.franchin\",\"profileId\":\"315390ab-d10f-41ca-adc8-b49de1978105\",\"creationDate\":\"2023-01-26\",\"ducVersion\":\"0.0.1\",\"permissionMode\":null,\"resources\":[{\"resourceName\":\"OPBG Research Biobank\",\"resourceDataLevel\":\"Biobank\",\"resourceContacts\":\"biobanca.ricerca@opbg.net \",\"resourceOrganisations\":[{\"resourceOrganisationName\":\"CHILDREN\'S HOSPITAL BAMBINO GESÙ\",\"resourceOrganisationRole\":\"Scientific Institute for Research, Hospitalization and Healthcare\"}]}],\"conditions\":[{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"GDPR UE 2016/679\"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"GDPR UE 2016/679\"},{\"useConditionLabel\":\"Research use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The informed consent clarifies the participant can claim the own samples back, whatever the reason (i.e., for clinical use). \"},{\"useConditionLabel\":\"Clinical research\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Disease specific use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The participant can choose if own samples may be used ONLY for research projects on the participant\'s disease or for other research projects on other diseases, too. \"},{\"useConditionLabel\":\"Use as control\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Clinical care\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Profit motivated use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"A patent development is allowed only with the consent of the participant, who cannot claim any rights to inventions.\"},{\"useConditionLabel\":\"Time period of use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Collaboration\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The participant is informed about the use of own biological samples. The requestor should send to the biobank a preview of all publications arising from or relating to the use of biospecimen or data, for the correct acknowledgment.\"},{\"useConditionLabel\":\"Fees\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Return of incidental findings\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\" \"},{\"useConditionLabel\":\"(Re-)identification of individuals without the involvement of the resource provider\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"(Re-)identification of individuals mediated by the resource provider\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Ethics Approval\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"User authentication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Publication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Return of results\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Publication moratorium\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"}],\"comments\":[{\"Comments Regarding CCE\":\"\"}]},\"resource\":[{\"resourceName\":\"OPBG Research Biobank\",\"resourceDataLevel\":\"Biobank\",\"resourceContacts\":\"biobanca.ricerca@opbg.net \",\"resourceOrganisations\":[{\"resourceOrganisationName\":\"CHILDREN\'S HOSPITAL BAMBINO GESÙ\",\"resourceOrganisationRole\":\"Scientific Institute for Research, Hospitalization and Healthcare\"}]}],\"Conditions\":[{\"useConditionLabel\":\"(Re-)identification of individuals mediated by the resource provider\",\"conditionDetailLabel\":\"Informed consent should facilitate a continuous dialogue with participants and inform them about the disease. The way of re-identification should be compliant with GDPR UE 2016/679 and with the participant\'s choices. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Clinical care\",\"conditionDetailLabel\":\"Patients shall have the right to request the biospecimen for diagnostic investigations.\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Clinical research\",\"conditionDetailLabel\":\"Patients shall be informed about the intetion of using biospecimens for advance medical knowledge.\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Collaboration\",\"conditionDetailLabel\":\"Participants are informed about the use of own biological samples. The requestor should send to the biobank a preview of all publications arising from or relating to the use of biospecimen or data, for the correct acknowledgment.\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Disease specific use\",\"conditionDetailLabel\":\"Participants can choose if samples may be used ONLY for research projects on the participant\'s disease or for other research projects on other diseases, too. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Ethics Approval\",\"conditionDetailLabel\":\"Legislative requirements.\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Fees\",\"conditionDetailLabel\":\"Our Institution views this as a collaborative research and we consider these fees as a reimbursement for the services provided under this project.\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Geographical area\",\"conditionDetailLabel\":\"GDPR UE 2016/679\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Publication\",\"conditionDetailLabel\":\"The access to the samples is only aimed for research purposes, , measurable through the publication fo research results. Each biobank that is used to perform a study is mentioned in the Methods section of the publication. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Publication moratorium\",\"conditionDetailLabel\":\"According to the partecipant\'s willingness.\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"conditionDetailLabel\":\"GDPR UE 2016/679\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Research use\",\"conditionDetailLabel\":\"Informed consent clarifies the participant can claim the own samples back, whatever the reason (i.e., for clinical use). \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Return of incidental findings\",\"conditionDetailLabel\":\" Health and wellness of the participant (and his/her family) shall be safeguarded. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Return of results\",\"conditionDetailLabel\":\"Health and wellness of the participant (and his/her family) shall be safeguarded. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Time period of use\",\"conditionDetailLabel\":\" Health and wellness of the participant (and his/her family) shall be safeguarded. \",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Use as control\",\"conditionDetailLabel\":\"Informed consent clarifies participants about the purpose of the biobanking. Participants shall choose about the sample\' use. \",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"(Re-)identification of individuals without the involvement of the resource provider\",\"conditionDetailLabel\":\"Informed consent should facilitate a continuous dialogue with participants and inform them about the disease. The way of re-identification should be compliant with GDPR UE 2016/679 and with the participant\'s choices. \",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Profit motivated use\",\"conditionDetailLabel\":\"A patent development is allowed only with the consent of the participant, who cannot claim any rights to inventions.\\n\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"conditionDetailLabel\":\"Our Institution does not provide samples for commercial entity and it is declares in the informed consent. \\n\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"otherConsiderations\":\"\"}]}'),(231,69,'0003706b-0df3-44e9-bee5-a218c889ec39','Test','{\r\n \"profile\": {\r\n \"profileName\": \"Test\",\r\n \"profileId\": \"0003706b-0df3-44e9-bee5-a218c889ec39\",\r\n \"creationDate\": \"2023-01-26\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Test resource\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Need to pay 19€ to access the resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Test resource\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Need to pay 19€ to access the resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(232,70,'5c481b56-e514-495c-9885-cdf5178f0a71','Francesco Colaci','{\r\n \"profile\": {\r\n \"profileName\": \"Francesco Colaci\",\r\n \"profileId\": \"5c481b56-e514-495c-9885-cdf5178f0a71\",\r\n \"creationDate\": \"2023-01-30\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Biobanca\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Biobanca\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(234,49,'b14fdaec-16ad-45c4-a539-feb615e16c91','IPGB','{\"profile\":{\"profileName\":\"IPGB\",\"profileVersion\":\"v2.0\",\"profileId\":\"b14fdaec-16ad-45c4-a539-feb615e16c91\",\"creationDate\":\"2023-02-02\",\"ducVersion\":\"0.0.1\",\"permissionMode\":null,\"resources\":[{\"resourceName\":\"IPGB\",\"resourceDescription\":\"disease oriented genetic biobank\",\"resourceDataLevel\":\"Biobank\",\"resourceOrganisations\":[{\"resourceOrganisationName\":\"IGB CNR\",\"resourceOrganisationRole\":\"IGB CNR\"}]}],\"conditions\":[{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist agrees to use this Material solely for application in the noncommercial research. Its distribution is limited to scientists at non-profit institutions solely for use in their own research.\"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The transfer of data to non-European countries must ensure the same protections of the GDPR in European countries.\"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Italy\"},{\"useConditionLabel\":\"Research use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The investigation must be carried out only in the context of medical and scientific research projects approved by an Ethics Committee\"},{\"useConditionLabel\":\"Clinical research\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Disease specific use\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The biological samples and associated data can be used exclusively for the performance of diagnostic tests and/ or scientific research carried out in the context of Incontinentia Pigmenti, but never for profit.\"},{\"useConditionLabel\":\"Use as control\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist must restitute the results to IPGB to allow the interpretation focused on Incontinentia pigmenti disease\"},{\"useConditionLabel\":\"Profit motivated use\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist agrees to use this Material solely for application in the noncommercial research. Its distribution is limited to scientists at non-profit institutions solely for use in their own research.\"},{\"useConditionLabel\":\"Return of results\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist must restitute the results to IPGB to allow the interpretation focused on Incontinentia pigmenti disease\"},{\"useConditionLabel\":\"Return of incidental findings\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"IPGB must receive the results of incidental findings and comunicate to the patient , according to his/her informed consent, of any unexpected results derived from any study /research.\"},{\"useConditionLabel\":\"(Re-)identification of individuals without the involvement of the resource provider\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The use of documents or samples deposited in the IPGB, always provided in unidentified form, must in no way be used to identify or re-identify one or more individuals from whom they were taken.\"},{\"useConditionLabel\":\"(Re-)identification of individuals mediated by the resource provider\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"the IPGB operates according to GDPR: the samples are transferred and used exclusively in coded form. The IPGB is obligated to identify or re-identify of an individual to allow a physician to feedback results or incidental findings.\"},{\"useConditionLabel\":\"Time period of use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"There is a predefinite time linked to the closure of the project; after that the forwarded material must be destroyed or returned to the IPGB Biobank\"},{\"useConditionLabel\":\"Collaboration\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The collaboration is obligatory because the staff of IPGB is group leader in the research and studies of Incontinentia pigmenti. Moreover the IPGB Biobank must be cited in the acknowledgments of any scientific production.\"},{\"useConditionLabel\":\"Fees\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist must pay any shipping fees.\"},{\"useConditionLabel\":\"Publication moratorium\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The use of samples and data from the IPGB entails the recipient\'s obligation not to publish the results of studies derived from the use of such samples and data before they are communicated to the IPGB. \"},{\"useConditionLabel\":\"Publication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The use of samples or data from the IPGB entails the recipient\'s obligation to make the results of studies conducted with the resource available to the scientific community, in accordance with the agreements with the IPGB when requesting the samples.\"},{\"useConditionLabel\":\"User authentication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Ethics Approval\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The investigation must be carried out only in the context of medical and scientific research projects approved by an Ethics Committee\"}],\"comments\":[{\"Comments Regarding CCE\":\"\"}]},\"resources\":[{\"resourceName\":\"IPGB\",\"resourceDescription\":\"disease oriented genetic biobank\",\"resourceDataLevel\":[\"Biobank\"],\"resourceContacts\":[\"\",\"\",\"incontinentia.pigmenti@igb.cnr.it\"],\"resourceOrganisations\":[{\"resourceOrganisationName\":\"IGB CNR\",\"resourceOrganisationRole\":\"IGB CNR\"}]}],\"Conditions\":[{\"useConditionLabel\":\"(Re-)identification of individuals mediated by the resource provider\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"the IPGB operates according to GDPR: the samples are transferred and used exclusively in coded form. The IPGB is obligated to identify or re-identify of an individual to allow a physician to feedback results or incidental findings.\"},{\"useConditionLabel\":\"(Re-)identification of individuals without the involvement of the resource provider\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The use of documents or samples deposited in the IPGB, always provided in unidentified form, must in no way be used to identify or re-identify one or more individuals from whom they were taken.\"},{\"useConditionLabel\":\"Clinical research\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Collaboration\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The collaboration is obligatory because the staff of IPGB is group leader in the research and studies of Incontinentia pigmenti. Moreover the IPGB Biobank must be cited in the acknowledgments of any scientific production.\"},{\"useConditionLabel\":\"Disease specific use\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The biological samples and associated data can be used exclusively for the performance of diagnostic tests and/ or scientific research carried out in the context of Incontinentia Pigmenti, but never for profit.\"},{\"useConditionLabel\":\"Ethics Approval\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The investigation must be carried out only in the context of medical and scientific research projects approved by an Ethics Committee\"},{\"useConditionLabel\":\"Fees\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist must pay any shipping fees.\"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The transfer of data to non-European countries must ensure the same protections of the GDPR in European countries.\"},{\"useConditionLabel\":\"Profit motivated use\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist agrees to use this Material solely for application in the noncommercial research. Its distribution is limited to scientists at non-profit institutions solely for use in their own research.\"},{\"useConditionLabel\":\"Publication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The use of samples or data from the IPGB entails the recipient\'s obligation to make the results of studies conducted with the resource available to the scientific community, in accordance with the agreements with the IPGB when requesting the samples.\"},{\"useConditionLabel\":\"Publication moratorium\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The use of samples and data from the IPGB entails the recipient\'s obligation not to publish the results of studies derived from the use of such samples and data before they are communicated to the IPGB. \"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Italy\"},{\"useConditionLabel\":\"Research use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The investigation must be carried out only in the context of medical and scientific research projects approved by an Ethics Committee\"},{\"useConditionLabel\":\"Return of incidental findings\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"IPGB must receive the results of incidental findings and comunicate to the patient , according to his/her informed consent, of any unexpected results derived from any study /research.\"},{\"useConditionLabel\":\"Return of results\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist must restitute the results to IPGB to allow the interpretation focused on Incontinentia pigmenti disease\"},{\"useConditionLabel\":\"Time period of use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"There is a predefinite time linked to the closure of the project; after that the forwarded material must be destroyed or returned to the IPGB Biobank\"},{\"useConditionLabel\":\"Use as control\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist must restitute the results to IPGB to allow the interpretation focused on Incontinentia pigmenti disease\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The Recipient Scientist agrees to use this Material solely for application in the noncommercial research. Its distribution is limited to scientists at non-profit institutions solely for use in their own research.\"},{\"useConditionLabel\":\"User authentication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\"}]}'),(244,43,'800bb65c-9f45-4359-945b-0340c9e0ddb9','VASCERN VASCA registry RadboudUMC CCE Profile','{\r\n \"profile\": {\r\n \"profileName\": \"VASCERN VASCA registry RadboudUMC CCE Profile\",\r\n \"profileVersion\": \"v0.2\",\r\n \"profileId\": \"800bb65c-9f45-4359-945b-0340c9e0ddb9\",\r\n \"creationDate\": \"2023-02-17\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDescription\": \"data on rare vascular anaomalies\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"depending on consent of participant\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"GDPR\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDescription\": \"data on rare vascular anaomalies\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"depending on consent of participant\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"GDPR\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(248,71,'pr_67gt0yt','ERKReg','{\"profile\":{\"profileID\":\"pr_67gt0yt\",\"profileName\":\"ERKReg\",\"profileVersion\":\"v0.1.4\",\"profileCreateDate\":\"2023-02-17\"},\"resource\":[{\"resourceName\":\"ERKReg\",\"resourceDescription\":\"Rare Kidney Diseases Patient Registry\",\"resourceDataLevel\":\"Patient Registry\"}],\"Conditions\":[{\"useConditionLabel\":\"(Re-)identification of individuals mediated by the resource provider\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"undefined\"},{\"useConditionLabel\":\"(Re-)identification of individuals without the involvement of the resource provider\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"undefined\"},{\"useConditionLabel\":\"Clinical care\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"uses to be discussed individually\"},{\"useConditionLabel\":\"Clinical research\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"uses to be discussed individually\"},{\"useConditionLabel\":\"Collaboration\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"undefined\"},{\"useConditionLabel\":\"Disease specific use\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"relating to kidney diseases\"},{\"useConditionLabel\":\"Fees\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"use for commercial or for-profit purposes\"},{\"useConditionLabel\":\"Profit motivated use\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"uses to be discussed individually\"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"use of data is only allowed where EU General Data Protection Regulation applies\"},{\"useConditionLabel\":\"Research use\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"uses to be discussed individually\"},{\"useConditionLabel\":\"Return of incidental findings\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"undefined\"},{\"useConditionLabel\":\"Return of results\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"areas that overlap with the uses from the supplying institution\"},{\"useConditionLabel\":\"Time period of use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"the recipient is permitted to use the data for no more than 1 year after the agreed completion date; to permit the preparation of the results for publication\"},{\"useConditionLabel\":\"Use as control\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"undefined\"},{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"undefined\"}],\"Comments\":[{\"Comments Regarding CCE\":\"\"}]}'),(250,51,'7f7690c4-2dd4-4108-9b98-eff43b451824','Test Biobank Profile 1','{\r\n \"profile\": {\r\n \"profileName\": \"Test Biobank Profile 1\",\r\n \"profileVersion\": \"Version 1.1 \",\r\n \"profileId\": \"7f7690c4-2dd4-4108-9b98-eff43b451824\",\r\n \"creationDate\": \"2023-02-21\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Biobank for disease X\",\r\n \"resourceDescription\": \"This is an example of a biobank that stores samples from patients that is primarily used in their treatment. However, samples are available to researchers where they are no longer needed for patient care. \",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"University of Leicester\",\r\n \"resourceOrganisationRole\": \"Biobank owener\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"While the resource is primarily a patient sample repository, excess samples can be used for research purposes. This includes use by commercial entities\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"European Union \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Use outside of the EU is subject to GDPR compliance and participant consent. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Resource use must adhere to the laws of the EU and the rulings of the European court of justice. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Research use is permitted subject to participant consent and sufficient sample to allow retention of a minimum stock for patient treatment. This use is subject to patient consent \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Samples collected from patients will be prioritised for clinical research over general research use, subject to patient consent \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Samples will be assessed for quality and suitability for use as a control sample. Their use is also subject to patient consent. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"All results must be returned to the resource, for interpretation in relation to the providing patient care\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Incidental findings must only be returned where this is consented to by the patient\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Samples are provided in a coded format and any further contact with the patient must be via the resource. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Users may contact the providing patients via the resource where the patients have given their consent to this. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"All resources are provided for the duration of the specified project plus an additional year in the first instance, to allow results to be generated and publications to be written. Extensions to the year, will be at the discretion of the resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Where use involves disease X the work must be performed in collaboration with the providing resource, who must be acknowledged appropriately in any publications. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Fees are charged on a cost recovery basis. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Users must not publish their findings where the research overlaps with that of the resource, without the approval of the resource. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The user is not under any obligation to publish findings. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The resource can only be used by authenticated researchers. They must provide documented proof of their affiliation with a recognised research organisation. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The user must provide documented evidence that their institution has ethically approved their proposed use of the resource. They must also provide documented proof that all relevant statutory approvals have been granted.\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Biobank for disease X\",\r\n \"resourceDescription\": \"This is an example of a biobank that stores samples from patients that is primarily used in their treatment. However, samples are available to researchers where they are no longer needed for patient care. \",\r\n \"resourceDataLevel\": \"Biobank\",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"University of Leicester\",\r\n \"resourceOrganisationRole\": \"Biobank owener\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"While the resource is primarily a patient sample repository, excess samples can be used for research purposes. This includes use by commercial entities\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"European Union \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Use outside of the EU is subject to GDPR compliance and participant consent. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Resource use must adhere to the laws of the EU and the rulings of the European court of justice. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Research use is permitted subject to participant consent and sufficient sample to allow retention of a minimum stock for patient treatment. This use is subject to patient consent \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Samples collected from patients will be prioritised for clinical research over general research use, subject to patient consent \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Samples will be assessed for quality and suitability for use as a control sample. Their use is also subject to patient consent. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"All results must be returned to the resource, for interpretation in relation to the providing patient care\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Incidental findings must only be returned where this is consented to by the patient\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Samples are provided in a coded format and any further contact with the patient must be via the resource. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Users may contact the providing patients via the resource where the patients have given their consent to this. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"All resources are provided for the duration of the specified project plus an additional year in the first instance, to allow results to be generated and publications to be written. Extensions to the year, will be at the discretion of the resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Where use involves disease X the work must be performed in collaboration with the providing resource, who must be acknowledged appropriately in any publications. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Fees are charged on a cost recovery basis. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Users must not publish their findings where the research overlaps with that of the resource, without the approval of the resource. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The user is not under any obligation to publish findings. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The resource can only be used by authenticated researchers. They must provide documented proof of their affiliation with a recognised research organisation. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The user must provide documented evidence that their institution has ethically approved their proposed use of the resource. They must also provide documented proof that all relevant statutory approvals have been granted.\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(251,50,'c9b7c00d-d4f1-4503-a2b6-c49eb59c6675','IRCCS Istituto G. Gaslini - Genetic Biobank','{\r\n \"profile\": {\r\n \"profileName\": \"IRCCS Istituto G. Gaslini - Genetic Biobank\",\r\n \"profileVersion\": \"version 4\",\r\n \"profileId\": \"c9b7c00d-d4f1-4503-a2b6-c49eb59c6675\",\r\n \"creationDate\": \"2023-02-21\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Biobank of the Laboratory of Human Genetics\",\r\n \"resourceDescription\": \"Genetic Biobank\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"only if it has been authorised in the informed consent \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"the use, in countries not covered by GDPR, requires specific authorisation included in the informed consent\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use in countries that are not covered by GDPR requires specific authorisation in the informed consent\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use for research purposes in the field of the disease for which the biological materials have been stored in the biobank. Most represented diseases: rare metabolic disorders, chromosome disorders, neurological diseases and overgrowth disorders\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use for research purposes , including research to improve diagnosis and treatment, in the field of the disease for which the biological materials have been biobanked. Specific authorisation in the informed consent is mandatory \\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"relating to the field of the disease for which the biological materials have been biobanked.\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use for diagnosis purpose, only if a specific authorisation in the informed consent is present\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"relating to the field of the disease for which the biological materials have been biobanked\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The recipient shall make available in confidence to the resource a final report of the results of the project\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"only for results that are relevant to the health of the participant\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"to allow the return of clinical relevant results to the participants\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The recipient is permitted to use the biological material until completion of the project for which the material has been required to the biobank . Terms and conditions for the use, storage and disposal of the material are stated in the MTA form.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The collaboration is evaluated when appropriate\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"distribution service related to funded projects is subject to cost-recovery. Not applicable for collaboration projects.\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The recipient agrees to make available to the resource the paper reprint (or pdf format) in case of publication. \\nThe recipients is asked to acknowledge the biobank in their publication.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"To request biological materials the recipient should register to the resource website and to fill in a specific form\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Protocol number, date and name of Ethical Committee/Review Board\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Biobank of the Laboratory of Human Genetics\",\r\n \"resourceDescription\": \"Genetic Biobank\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"only if it has been authorised in the informed consent \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"the use, in countries not covered by GDPR, requires specific authorisation included in the informed consent\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use in countries that are not covered by GDPR requires specific authorisation in the informed consent\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use for research purposes in the field of the disease for which the biological materials have been stored in the biobank. Most represented diseases: rare metabolic disorders, chromosome disorders, neurological diseases and overgrowth disorders\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use for research purposes , including research to improve diagnosis and treatment, in the field of the disease for which the biological materials have been biobanked. Specific authorisation in the informed consent is mandatory \\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"relating to the field of the disease for which the biological materials have been biobanked.\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"use for diagnosis purpose, only if a specific authorisation in the informed consent is present\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"relating to the field of the disease for which the biological materials have been biobanked\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The recipient shall make available in confidence to the resource a final report of the results of the project\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"only for results that are relevant to the health of the participant\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"to allow the return of clinical relevant results to the participants\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The recipient is permitted to use the biological material until completion of the project for which the material has been required to the biobank . Terms and conditions for the use, storage and disposal of the material are stated in the MTA form.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The collaboration is evaluated when appropriate\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Fees\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"distribution service related to funded projects is subject to cost-recovery. Not applicable for collaboration projects.\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"The recipient agrees to make available to the resource the paper reprint (or pdf format) in case of publication. \\nThe recipients is asked to acknowledge the biobank in their publication.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"To request biological materials the recipient should register to the resource website and to fill in a specific form\\n\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Protocol number, date and name of Ethical Committee/Review Board\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(252,51,'pr_67n6kiw','Test Biobank Profile 2','{\"profile\":{\"profileName\":\"Test Biobank Profile 2\",\"profileVersion\":\"Version 1.1 \",\"profileID\":\"pr_67n6kiw\",\"profileCreateDate\":\"2023-02-21\"},\"resources\":[{\"resourceName\":\"Biobank for disease X\",\"resourceDescription\":\"This is an example of a biobank that stores samples from patients that is primarily used in their treatment. However, samples are available to researchers where they are no longer needed for patient care. \",\"resourceDataLevel\":\"Biobank\",\"resourceOrganisations\":[{\"resourceOrganisationName\":\"University of Leicester\",\"resourceOrganisationRole\":\"Biobank owener\"}]}],\"Conditions\":[{\"useConditionLabel\":\"(Re-)identification of individuals mediated by the resource provider\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Users may contact the providing patients via the resource where the patients have given their consent to this. \"},{\"useConditionLabel\":\"(Re-)identification of individuals without the involvement of the resource provider\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Samples are provided in a coded format and any further contact with the patient must be via the resource. \"},{\"useConditionLabel\":\"Clinical research\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Samples collected from patients will be prioritised for clinical research over general research use, subject to patient consent \"},{\"useConditionLabel\":\"Collaboration\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Where use involves disease X the work must be performed in collaboration with the providing resource, who must be acknowledged appropriately in any publications. \"},{\"useConditionLabel\":\"Ethics Approval\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The user must provide documented evidence that their institution has ethically approved their proposed use of the resource. They must also provide documented proof that all relevant statutory approvals have been granted.\"},{\"useConditionLabel\":\"Fees\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Fees are charged on a cost recovery basis. \"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"European Union \"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Use outside of the EU is subject to GDPR compliance and participant consent. \"},{\"useConditionLabel\":\"Profit motivated use\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Publication\",\"rule\":\"No Requirements\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The user is not under any obligation to publish findings. \"},{\"useConditionLabel\":\"Publication moratorium\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Users must not publish their findings where the research overlaps with that of the resource, without the approval of the resource. \"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Resource use must adhere to the laws of the EU and the rulings of the European court of justice. \"},{\"useConditionLabel\":\"Research use\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Research use is permitted subject to participant consent and sufficient sample to allow retention of a minimum stock for patient treatment. This use is subject to patient consent \"},{\"useConditionLabel\":\"Return of incidental findings\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Incidental findings must only be returned where this is consented to by the patient\"},{\"useConditionLabel\":\"Return of results\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"All results must be returned to the resource, for interpretation in relation to the providing patient care\"},{\"useConditionLabel\":\"Time period of use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"All resources are provided for the duration of the specified project plus an additional year in the first instance, to allow results to be generated and publications to be written. Extensions to the year, will be at the discretion of the resource\"},{\"useConditionLabel\":\"Use as control\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Samples will be assessed for quality and suitability for use as a control sample. Their use is also subject to patient consent. \"},{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"While the resource is primarily a patient sample repository, excess samples can be used for research purposes. This includes use by commercial entities\"},{\"useConditionLabel\":\"User authentication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The resource can only be used by authenticated researchers. They must provide documented proof of their affiliation with a recognised research organisation. \"}]}'),(253,51,'pr_r1c4xz','Test Biobank Profile 1','{\"profile\":{\"profileID\":\"pr_r1c4xz\",\"profileName\":\"Test Biobank Profile 1\",\"profileVersion\":\"Version 1.1 \",\"profileCreateDate\":\"2023-02-21\"},\"resource\":[{\"resourceName\":\"Biobank for disease X\",\"resourceDescription\":\"This is an example of a biobank that stores samples from patients that is primarily used in their treatment. However, samples are available to researchers where they are no longer needed for patient care. \",\"resourceDataLevel\":\"Biobank\",\"resourceOrganisations\":[{\"resourceOrganisationName\":\"University of Leicester\",\"resourceOrganisationRole\":\"Biobank owener\"}]}],\"Conditions\":[{\"useConditionLabel\":\"Use by a commercial entity\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"While the resource is primarily a patient sample repository, excess samples can be used for research purposes. This includes use by commercial entities\"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Permitted\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"European Union \"},{\"useConditionLabel\":\"Geographical area\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Use outside of the EU is subject to GDPR compliance and participant consent. \"},{\"useConditionLabel\":\"Regulatory jurisdiction\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Resource use must adhere to the laws of the EU and the rulings of the European court of justice. \"},{\"useConditionLabel\":\"Research use\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Research use is permitted subject to participant consent and sufficient sample to allow retention of a minimum stock for patient treatment. This use is subject to patient consent \"},{\"useConditionLabel\":\"Clinical research\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Samples collected from patients will be prioritised for clinical research over general research use, subject to patient consent \"},{\"useConditionLabel\":\"Use as control\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Samples will be assessed for quality and suitability for use as a control sample. Their use is also subject to patient consent. \"},{\"useConditionLabel\":\"Profit motivated use\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\"},{\"useConditionLabel\":\"Return of results\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"All results must be returned to the resource, for interpretation in relation to the providing patient care\"},{\"useConditionLabel\":\"Return of incidental findings\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Incidental findings must only be returned where this is consented to by the patient\"},{\"useConditionLabel\":\"(Re-)identification of individuals without the involvement of the resource provider\",\"rule\":\"Forbidden\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Samples are provided in a coded format and any further contact with the patient must be via the resource. \"},{\"useConditionLabel\":\"(Re-)identification of individuals mediated by the resource provider\",\"rule\":\"Permitted\",\"scope\":\"Part of Resource\",\"conditionDetailLabel\":\"Users may contact the providing patients via the resource where the patients have given their consent to this. \"},{\"useConditionLabel\":\"Time period of use\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"All resources are provided for the duration of the specified project plus an additional year in the first instance, to allow results to be generated and publications to be written. Extensions to the year, will be at the discretion of the resource\"},{\"useConditionLabel\":\"Collaboration\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Where use involves disease X the work must be performed in collaboration with the providing resource, who must be acknowledged appropriately in any publications. \"},{\"useConditionLabel\":\"Fees\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Fees are charged on a cost recovery basis. \"},{\"useConditionLabel\":\"Publication moratorium\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"Users must not publish their findings where the research overlaps with that of the resource, without the approval of the resource. \"},{\"useConditionLabel\":\"Publication\",\"rule\":\"No Requirements\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The user is not under any obligation to publish findings. \"},{\"useConditionLabel\":\"User authentication\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The resource can only be used by authenticated researchers. They must provide documented proof of their affiliation with a recognised research organisation. \"},{\"useConditionLabel\":\"Ethics Approval\",\"rule\":\"Obligated\",\"scope\":\"Whole of Resource\",\"conditionDetailLabel\":\"The user must provide documented evidence that their institution has ethically approved their proposed use of the resource. They must also provide documented proof that all relevant statutory approvals have been granted.\"}],\"Comments\":[{\"Comments Regarding CCE\":\"\"}]}'),(254,72,'6f05fc32-8ffa-46bb-9532-578afaf39271','Profile 1','{\r\n \"profile\": {\r\n \"profileName\": \"Profile 1\",\r\n \"profileVersion\": \"1.0\",\r\n \"profileId\": \"6f05fc32-8ffa-46bb-9532-578afaf39271\",\r\n \"creationDate\": \"2023-02-24\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"resource\",\r\n \"resourceDataLevel\": \"Guideline\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"resource\",\r\n \"resourceDataLevel\": \"Guideline\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(255,72,'09e318cd-1ae2-4add-8e56-0f679009ff38','Profile 2','{\r\n \"profile\": {\r\n \"profileName\": \"Profile 2\",\r\n \"profileVersion\": \"2.0\",\r\n \"profileId\": \"09e318cd-1ae2-4add-8e56-0f679009ff38\",\r\n \"creationDate\": \"2023-02-24\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"resource\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"resource\",\r\n \"resourceDataLevel\": \"Biobank\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(256,72,'c1928c13-e861-4e65-a78f-8988665032fc','Profile 3','{\r\n \"profile\": {\r\n \"profileName\": \"Profile 3\",\r\n \"profileVersion\": \"1.0\",\r\n \"profileId\": \"c1928c13-e861-4e65-a78f-8988665032fc\",\r\n \"creationDate\": \"2023-02-27\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"resource\",\r\n \"resourceDataLevel\": \"Guideline\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"test\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"resource\",\r\n \"resourceDataLevel\": \"Guideline\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"test\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(257,73,'09a13388-438b-481c-83cd-833337a8db21','ERN eUROGEN registry','{\r\n \"profile\": {\r\n \"profileName\": \"ERN eUROGEN registry\",\r\n \"profileVersion\": \"1\",\r\n \"profileId\": \"09a13388-438b-481c-83cd-833337a8db21\",\r\n \"creationDate\": \"2023-02-28\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"ERN eUROGEN registry\",\r\n \"resourceDescription\": \"Data on rare uro-recto-genital diseases and complex conditions\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"GDPR\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"ERN eUROGEN registry\",\r\n \"resourceDescription\": \"Data on rare uro-recto-genital diseases and complex conditions\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"GDPR\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(258,63,'ecd3e62e-8423-4330-b78a-c6d03971d012','ERN-Registry-Research-ICF_CCEs applicable to all versions_No1','{\r\n \"profile\": {\r\n \"profileName\": \"ERN-Registry-Research-ICF_CCEs applicable to all versions_No1\",\r\n \"profileVersion\": \"v1.1\",\r\n \"profileId\": \"ecd3e62e-8423-4330-b78a-c6d03971d012\",\r\n \"creationDate\": \"2023-03-09\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. The use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. The use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be transferred to non-EU countries, in compliance with GDPR, to support projects aimed to improve healthcare.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be linked to existing databases/registries to improve healthcare. It should be \\\"permitted\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition.It should be \\\"permitted\\\" and should be a new voice \\\"re-contact\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE INFORMED by my medical doctor about any incidental finding that is directly relevant to my personal health or to the health of my family members. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"1.Consideration on statement n9: GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use.\\n2. \\tLimited number of characters in the fields \\\"condition detail\\\". Some considerations might be put in the field \\\"Comments regarding CCE\\\". The information provided in the \\\"Comments regarding CCE\\\" needs to be displayed in the \\\"Summary\\\". It is not for the moment.\\n3. Use condition \\\"fee\\\": depends on ERN data strategy and the type of stakeholder requesting data access (e.g., fees may apply for industry requesting access to registry data).\\n4.Use condition \\\"Return of results\\\": The results of the research will be communicated through the mean decided by the ERN (e.g., registry website [The information about projects given access to registry data is publicly available on the registry website.], OR information provided by the patient’s medical doctor upon request, OR publication in scientific journals where personal data are not provided, etc.). The privacy of the patient\'s data will always be protected as described in the ICF.\\n5.Use condition \\\"publication\\\": is considered as being part of the use condition \\\"return of results\\\"`\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"ERN registry\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Research use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. The use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical research\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided. The use of the registry for healthcare purposes (not research) is obligated for the whole registry (resource)\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of results\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Disease specific use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Disease specific use \\\"Permitted\\\". However, there is no restriction to \\\"non-disease specific\\\" use\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Clinical care\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"By default Clinical care is \\\"Obligated\\\" for the \\\"Whole Registry\\\". The research targeted ERN ICF does not contain specific consent condition for \\\"clinical care\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use as control\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals mediated by the resource provider\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\",\r\n \"conditionDetailLabel\": \"Part of the resource because this is restricted to the patient\'s dateset for which the version of the consent (Consent-All) was provided\"\r\n },\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Time period of use\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"For a paediatric patient: re-consent is necessary when the patient reaches the legal age of competence. Time period of use of the dataset of a pediatric patient ends when this patient reaches the legal age of competence.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication moratorium\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Publication\",\r\n \"rule\": \"No Requirements\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"User authentication\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Geographical area\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be transferred to non-EU countries, in compliance with GDPR, to support projects aimed to improve healthcare.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Use by a commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare.\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may be linked to existing databases/registries to improve healthcare. It should be \\\"permitted\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Collaboration\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE CONTACTED by my medical doctor about any research project and/or clinical study related to my condition.It should be \\\"permitted\\\" and should be a new voice \\\"re-contact\\\"\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Return of incidental findings\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I WOULD LIKE TO BE INFORMED by my medical doctor about any incidental finding that is directly relevant to my personal health or to the health of my family members. \"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"I CONSENT that my pseudonymized data may also be used to support commercial projects aimed to improve healthcare. \"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"1.Consideration on statement n9: GDPR requires the definition of a time period of use or, if not defined, the criteria to determine the time period of use.\\n2. \\tLimited number of characters in the fields \\\"condition detail\\\". Some considerations might be put in the field \\\"Comments regarding CCE\\\". The information provided in the \\\"Comments regarding CCE\\\" needs to be displayed in the \\\"Summary\\\". It is not for the moment.\\n3. Use condition \\\"fee\\\": depends on ERN data strategy and the type of stakeholder requesting data access (e.g., fees may apply for industry requesting access to registry data).\\n4.Use condition \\\"Return of results\\\": The results of the research will be communicated through the mean decided by the ERN (e.g., registry website [The information about projects given access to registry data is publicly available on the registry website.], OR information provided by the patient’s medical doctor upon request, OR publication in scientific journals where personal data are not provided, etc.). The privacy of the patient\'s data will always be protected as described in the ICF.\\n5.Use condition \\\"publication\\\": is considered as being part of the use condition \\\"return of results\\\"`\"\r\n }\r\n ]\r\n}'),(259,34,'60ea21f6-a76b-434d-9f62-393e70cd731e','Profile Name is here','{\r\n \"profile\": {\r\n \"profileName\": \"Profile Name is here\",\r\n \"profileVersion\": \"0.0.1\",\r\n \"profileId\": \"60ea21f6-a76b-434d-9f62-393e70cd731e\",\r\n \"creationDate\": \"2023-05-25\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Reseource Name is here\",\r\n \"resourceDescription\": \"Description is here\",\r\n \"resourceDataLevel\": \"Dataset\",\r\n \"resourceContacts\": \"a@email.com \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"Org 1 \",\r\n \"resourceOrganisationRole\": \"Org 1 role\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Condition detail is here\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Reseource Name is here\",\r\n \"resourceDescription\": \"Description is here\",\r\n \"resourceDataLevel\": \"Dataset\",\r\n \"resourceContacts\": \"a@email.com \",\r\n \"resourceOrganisations\": [\r\n {\r\n \"resourceOrganisationName\": \"Org 1 \",\r\n \"resourceOrganisationRole\": \"Org 1 role\"\r\n }\r\n ]\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Commercial entity\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"Condition detail is here\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(260,43,'f27d1f18-56c8-4d21-b06a-59c6d3c70faf','VASCERN VASCA registry RadboudUMC CCE Profile','{\r\n \"profile\": {\r\n \"profileName\": \"VASCERN VASCA registry RadboudUMC CCE Profile\",\r\n \"profileVersion\": \"v0.2\",\r\n \"profileId\": \"f27d1f18-56c8-4d21-b06a-59c6d3c70faf\",\r\n \"creationDate\": \"2023-06-06\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDescription\": \"data on rare vascular anaomalies\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"GDPR\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"Radboudumc VASCA data\",\r\n \"resourceDescription\": \"data on rare vascular anaomalies\",\r\n \"resourceDataLevel\": \"Patient Registry\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"(Re-)identification of individuals without the involvement of the resource provider\",\r\n \"rule\": \"Forbidden\",\r\n \"scope\": \"Whole of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Profit motivated use\",\r\n \"rule\": \"Permitted\",\r\n \"scope\": \"Part of Resource\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Regulatory jurisdiction\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionDetailLabel\": \"GDPR\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}'),(261,74,'0c3763ad-1859-4f82-aca1-040776f1344e','test','{\r\n \"profile\": {\r\n \"profileName\": \"test\",\r\n \"profileVersion\": \"0.0.1\",\r\n \"profileId\": \"0c3763ad-1859-4f82-aca1-040776f1344e\",\r\n \"creationDate\": \"2023-08-22\",\r\n \"ducVersion\": \"0.0.1\",\r\n \"permissionMode\": null,\r\n \"resources\": [\r\n {\r\n \"resourceName\": \"HBU\"\r\n }\r\n ],\r\n \"conditions\": [\r\n {\r\n \"useConditionLabel\": \"Publication Moratorium\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionParameter\": \"any publication must be sent to data provider 21 days before the submission\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionParameter\": \"any use of data requires valid ethics approval\"\r\n }\r\n ],\r\n \"comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n },\r\n \"resource\": [\r\n {\r\n \"resourceName\": \"HBU\"\r\n }\r\n ],\r\n \"Conditions\": [\r\n {\r\n \"useConditionLabel\": \"Publication Moratorium\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionParameter\": \"any publication must be sent to data provider 21 days before the submission\"\r\n },\r\n {\r\n \"useConditionLabel\": \"Ethics Approval\",\r\n \"rule\": \"Obligated\",\r\n \"scope\": \"Whole of Resource\",\r\n \"conditionParameter\": \"any use of data requires valid ethics approval\"\r\n }\r\n ],\r\n \"Comments\": [\r\n {\r\n \"Comments Regarding CCE\": \"\"\r\n }\r\n ]\r\n}');
/*!40000 ALTER TABLE `profile` ENABLE KEYS */;
UNLOCK TABLES;
--
-- Table structure for table `querylogic`
--
DROP TABLE IF EXISTS `querylogic`;
/*!40101 SET @saved_cs_client = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `querylogic` (
`l_id` bigint(20) NOT NULL,
`p_id` bigint(20) NOT NULL,
`cce` varchar(500) NOT NULL,
`q_rule` varchar(500) NOT NULL,
`result` varchar(500) NOT NULL,
PRIMARY KEY (`l_id`),
KEY `querylogic_ibfk_1` (`p_id`),
CONSTRAINT `querylogic_ibfk_1` FOREIGN KEY (`p_id`) REFERENCES `profile` (`p_id`)
) ENGINE=InnoDB DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;
--
-- Dumping data for table `querylogic`
--
LOCK TABLES `querylogic` WRITE;
/*!40000 ALTER TABLE `querylogic` DISABLE KEYS */;
/*!40000 ALTER TABLE `querylogic` ENABLE KEYS */;
UNLOCK TABLES;
--
-- Table structure for table `userinfo`
--
DROP TABLE IF EXISTS `userinfo`;
/*!40101 SET @saved_cs_client = @@character_set_client */;
/*!40101 SET character_set_client = utf8 */;
CREATE TABLE `userinfo` (
`u_id` bigint(20) NOT NULL AUTO_INCREMENT,
`u_fname` varchar(500) NOT NULL,
`u_lname` varchar(500) NOT NULL,
`u_email` varchar(500) NOT NULL,
`u_role` varchar(1000) NOT NULL,
PRIMARY KEY (`u_id`)
) ENGINE=InnoDB AUTO_INCREMENT=75 DEFAULT CHARSET=utf8mb4 COLLATE=utf8mb4_general_ci;
/*!40101 SET character_set_client = @saved_cs_client */;
--
-- Dumping data for table `userinfo`
--
LOCK TABLES `userinfo` WRITE;
/*!40000 ALTER TABLE `userinfo` DISABLE KEYS */;
INSERT INTO `userinfo` VALUES (34,'Umar','Riaz','umarriaz56@gmail.com','Developer'),(35,'Spence','Gibson','spencer.gibson@leicester.ac.uk','Research Associate'),(40,'Colin','Veal','cdv1@leicester.ac.uk','admin'),(41,'Colin','Veal','cdv','test'),(42,'','','cdv1@leicester.ac.uk',''),(43,'P','K','pim.kamerling@radboudumc.nl',''),(44,'Spencer','Gibson','sg307@leicester.ac.uk',''),(45,'M','S','mcsanchez@isciii.es',''),(46,'Nosheen','Hanif','hanifna@hotmail.co.uk',''),(47,'Alessandro ','Sulis','alessandro.sulis@crs4.it',''),(48,'Rodrigo','Barnes','rodrigo.barnes@aridhia.com',''),(49,'Francesca','Fusco','incontinentia.pigmenti@igb.cnr.it',''),(50,'Domenico','Coviello','geneticbiobank@gaslini.org',''),(51,'Spencer','Gibson','sg307@le.ac.uk',''),(52,'Francis','Jeanson','fjeanson@yahoo.com',''),(53,'Nancy','Mah','nancy.mah@ibmt.fraunhofer.de',''),(54,'','','nancy.mah@ibmt.fraunhofer.de',''),(55,'Clémence','Le Cornec','Clemence.LeCornec@med.uni-heidelberg.de',''),(56,'da','dsd','cdv1@leicester.ac.uk',''),(57,'Test','User (greeting to Tony and Spencer)','heimo.mueller@mac.com',''),(58,'David','Gee','me@dave.dev',''),(59,'Nawel','Lalout','nawel.lalout@worldduchenne.org',''),(60,'Loes','van der Zanden','loes.vanderzanden@radboudumc.nl',''),(61,'Davit','Chokoshvili','davit.chokoshvili@gmail.com',''),(62,'Yanis Annalisa','Mimouni Landi','yanis.mimouni@ejprd-project.eu',''),(63,'Annalisa','Landi','al@benzifoundation.org',''),(64,'Morris','Swertz','m.a.swertz@gmail.com',''),(65,'','','1zqjcr\'\"(){}<x>:/1zqjcr;9',''),(66,'Umar','Riaz','uriraz13@gmail.com',''),(67,'Umar','Riaz','urriaz13@gmail.com',''),(68,'Tiziana','Franchin','tiziana.franchin@opbg.net',''),(69,'Oussama','Benhamed','oussama.benhamed@alumnos.upm.es',''),(70,'Francesco','Colaci','francesco.colaci@ausl.bologna.it',''),(71,'Jose','Ramirez','JoseAntonio.RamirezGarcia@med.uni-heidelberg.de',''),(72,'Sean','','seanraisi@hotmail.co.uk',''),(73,'Lotte','Boormans','lotte.boormans@radboudumc.nl',''),(74,'vilem','ded','ded.v@seznam.cz','');
/*!40000 ALTER TABLE `userinfo` ENABLE KEYS */;
UNLOCK TABLES;
/*!40103 SET TIME_ZONE=@OLD_TIME_ZONE */;
/*!40101 SET SQL_MODE=@OLD_SQL_MODE */;
/*!40014 SET FOREIGN_KEY_CHECKS=@OLD_FOREIGN_KEY_CHECKS */;
/*!40014 SET UNIQUE_CHECKS=@OLD_UNIQUE_CHECKS */;
/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
/*!40111 SET SQL_NOTES=@OLD_SQL_NOTES */;
-- Dump completed on 2023-08-24 15:50:14